On the stock market since 2006, it operates in the world of health and science. It has 13 employees. Now — the numbers.
This is an established company with proven profits.
No real growth. Red columns mark years that ended in a loss.
The gap is $15.4M. In times of high interest rates, a gap like that can squeeze a company.
Executives buying with their own money is usually read as confidence in the company’s future.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Profit per Sale: The profit kept from each sale is thin.
An investor who bought at the very peak is down 92% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Over the last 12 months, company executives reported 14 buys and 9 sells. Management buying with its own money is usually read as a good sign.
The stock sits at $0.20. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
The company’s market value is 74 times its annual profit. Even a small disappointment could hit the price hard.
On our five-subject report card, CYDY sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: CYDY is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.